218 related articles for article (PubMed ID: 9723711)
41. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
42. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
43. Follicular dendritic cells help resting B cells to become effective antigen-presenting cells: induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules.
Kosco-Vilbois MH; Gray D; Scheidegger D; Julius M
J Exp Med; 1993 Dec; 178(6):2055-66. PubMed ID: 7504055
[TBL] [Abstract][Full Text] [Related]
44. DNA-mediated transfer of major histocompatibility class II I-Ab and I-Abm12 genes into B lymphoma cells: molecular and functional analysis of introduced antigens.
Ben-Nun A; Choi E; McIntyre KR; Leeman SA; McKean DJ; Seidman JG; Glimcher LH
J Immunol; 1985 Aug; 135(2):1456-64. PubMed ID: 3925010
[TBL] [Abstract][Full Text] [Related]
45. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
Wither JE; Vukusic B
J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
[TBL] [Abstract][Full Text] [Related]
46. Immunological synapse formation licenses CD40-CD40L accumulations at T-APC contact sites.
Boisvert J; Edmondson S; Krummel MF
J Immunol; 2004 Sep; 173(6):3647-52. PubMed ID: 15356109
[TBL] [Abstract][Full Text] [Related]
47. Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme.
Brooks A; Hartley S; Kjer-Nielsen L; Perera J; Goodnow CC; Basten A; McCluskey J
Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3290-4. PubMed ID: 1707537
[TBL] [Abstract][Full Text] [Related]
48. Functional and molecular characterization of I-A kappa beta mutants is consistent with the predicted three dimensional structure of class II MHC molecules.
Brown MA; Griffith IJ; Glimcher LH
Mol Immunol; 1990 Jul; 27(7):645-50. PubMed ID: 2395436
[TBL] [Abstract][Full Text] [Related]
49. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression.
Nabavi N; Freeman GJ; Gault A; Godfrey D; Nadler LM; Glimcher LH
Nature; 1992 Nov; 360(6401):266-8. PubMed ID: 1279442
[TBL] [Abstract][Full Text] [Related]
50. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
51. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
[TBL] [Abstract][Full Text] [Related]
52. CD54/intercellular adhesion molecule 1 and major histocompatibility complex II signaling induces B cells to express interleukin 2 receptors and complements help provided through CD40 ligation.
Poudrier J; Owens T
J Exp Med; 1994 May; 179(5):1417-27. PubMed ID: 7513009
[TBL] [Abstract][Full Text] [Related]
53. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
Brown JH; Jardetzky TS; Gorga JC; Stern LJ; Urban RG; Strominger JL; Wiley DC
Nature; 1993 Jul; 364(6432):33-9. PubMed ID: 8316295
[TBL] [Abstract][Full Text] [Related]
54. In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.
Dongre AR; Kovats S; deRoos P; McCormack AL; Nakagawa T; Paharkova-Vatchkova V; Eng J; Caldwell H; Yates JR; Rudensky AY
Eur J Immunol; 2001 May; 31(5):1485-94. PubMed ID: 11465105
[TBL] [Abstract][Full Text] [Related]
55. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
Brazil MI; Weiss S; Stockinger B
Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
[TBL] [Abstract][Full Text] [Related]
56. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
Nieland JD; Kruisbeek AM
Int Immunol; 1995 Nov; 7(11):1827-38. PubMed ID: 8580081
[TBL] [Abstract][Full Text] [Related]
57. Analysis of antigen presentation using HLA transfectants.
Altmann DM; Wilkinson D; Ikeda H; Trowsdale J
Immunol Res; 1990; 9(1):57-68. PubMed ID: 2406352
[No Abstract] [Full Text] [Related]
58. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
Eckels DD; Geiger MJ; Sell TW; Gorski JA
Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
[TBL] [Abstract][Full Text] [Related]
59. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
Agrawal B; Fraga E; Kane K; Singh B
J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
[TBL] [Abstract][Full Text] [Related]
60. Ek beta mutant antigen-presenting cell lines expressing altered Ak alpha molecules.
Quill H; Schwartz RH; Glimcher LH
J Immunol; 1986 May; 136(9):3351-9. PubMed ID: 3082986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
